Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
40.25 HKD | +2.81% | +18.56% | -5.85% |
04-17 | Innovent Appoints Dr. Nageatte Ibrahim as the Oncology Chief Medical Officer | CI |
04-02 | Hutchmed endometrial cancer treatment application accepted for review | AN |
- Stock Market
- Equities
- 1801 Stock
- News Innovent Biologics, Inc.